A recent study focused on nine idiopathic pediatric patients with mutations in DAGLα and a specific set of symptoms: ataxia, nystagmus, and developmental delay (Bainbridge et al., 2022). The gene discussed is DAGLA; the disease is pathologic nystagmus.